Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NicVAX fMRI study in smokers
NCT01318668Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Feb 2011
- Primary completion
- Jun 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NicVAX in nicotine dependence, sponsored by Maastricht University Medical Center+. Started Feb 2011; status: completed.
02
Drugs
NicVAX
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01318668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01318668.